News in the Life Sciences Industry

SUZHOU, China, Jan. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced... Read more ››

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical... Read more ››

OMAHA, Neb., Jan. 13, 2020 /PRNewswire/ -- Gary F. Moore, M.D. F.A.C.S. is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of medicine as a Doctor in Neurotology. Dr. Moore also has expertise in Otolaryngology, skull vase surgery, balance, hearing loss,... Read more ››

CHICAGO, Jan. 14, 2020 /PRNewswire/ -- An incentive prize ten times the size of the Nobel - believed to be the largest single award ever in basic science - is being offered to the person or team solving the largest mystery in history: how genetic code inside cells got there, and how cells intentionally... Read more ››

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The Read more ››

STOUGHTON, Mass., Jan. 13, 2020 /PRNewswire/ -- Primo Medical Group, a Massachusetts based medical device manufacturer and incubator, is pleased to announce the sale of its spin-off company Arthrosurface, to Anika Therapeutics.

NEW YORK, Jan. 13, 2020 /PRNewswire/ -- The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027.

WASHINGTON, Jan. 13, 2020 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) on Monday announced it has streamlined the process to survey the nation's psychiatric hospitals to review for compliance with participation requirements in one comprehensive survey.

NEW YORK, Jan. 13, 2020 /PRNewswire/ --

HACKENSACK, N.J., Jan. 13, 2020 /PRNewswire/ -- Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey were part of the CANDOR global phase III clinical trial for patients with refractory (persistent) multiple myeloma. The study was selected as the prestigious... Read more ››

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The Read more ››

SAN DIEGO, Jan. 13, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today the appointment... Read more ››

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The Read more ››